PARIS & BOULDER, Colo.–(BUSINESS WIRE)–Regulatory Information:
SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an progressive firm that deploys its DSG® (Dynamic Surgical Steerage) sensing expertise to safe and streamline the position of bone implants, declares that, because of lack of quorum, its Annual Shareholders’ assembly held on June 9, 2021 couldn’t be held.
Shareholders are hereby notified that the Annual Shareholders’ Assembly can be held on second name on Wednesday, June 30, 2021 at 8:45 am CEST in a closed digital session by the use of a stay webcast.
The Shareholder’s Assembly can be held on the identical agenda and with the identical situations of participation as on the time of the primary name (see Press Release of May 21, 2021).
The dearth of quorum didn’t permit to resolve on the odd and extraordinary resolutions.
The shareholders of the corporate who didn’t solid their vote till now are invited to take action remotely, earlier than the Shareholder’s Assembly on 2nd name:
– e-voting utilizing “Votaccess” is obtainable and ought to be prioritized. To this finish, the Firm informs its shareholders that for the primary time, SpineGuard has arrange an web voting system. The safe voting platform Votaccess can be reopened on Friday, June 11, 2021 at 9:00 am CEST and closed once more on Tuesday, June 29 at 3:00 pm CEST.
– Alternatively, voting by proxy can be out there in keeping with the procedures indicated within the discover of assembly printed within the BALO on Could 3, 2021. The deadline to solid votes by proxy is Friday June 25, 2021.
For all questions concerning voting procedures, please consult with the Investor Relations staff by e-mail: email@example.com
Based in 2009 in France and the USA by Pierre Jérôme and Stéphane Bette, SpineGuard is an progressive firm deploying its proprietary radiation-free actual time sensing expertise DSG® (Dynamic Surgical Steerage) to safe and streamline the position of implants within the skeleton. SpineGuard designs, develops and markets medical gadgets which were utilized in over 80,000 surgical procedures worldwide. Seventeen research printed in peer-reviewed scientific journals have demonstrated the a number of advantages DSG® presents to sufferers, surgeons, surgical employees and hospitals. Constructing on these strong fundamentals and several other strategic partnerships, SpineGuard has expanded its expertise platform in a disruptive innovation: the « sensible » pedicle screw launched late 2017 and is broadening the scope of purposes in dental implantology and surgical robotics. DSG® was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer.
For additional info, go to www.spineguard.com
The SpineGuard securities will not be provided or bought in the US as they haven’t been and won’t be registered underneath the Securities Act or any United States state securities legal guidelines, and SpineGuard doesn’t intend to make a public provide of its securities in the US. That is an announcement and never a prospectus, and the data contained herein does and shall not represent a suggestion to promote or the solicitation of a suggestion to purchase, nor shall there be any sale of the securities referred to herein in the US through which such provide, solicitation or sale could be illegal previous to registration or exemption from registration.
CEO & Chairman
Tel: +33 1 45 18 45 19
Tel: +33 1 45 18 45 19
Investor Relations & Monetary Communication
Mathilde Bohin / Pierre Laurent
Tel.: +33 1 44 71 94 94